EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers

Eva P Cuevas, Enrique Madruga, Ignacio Valenzuela-Martínez, David Ramírez, Carmen Gil, Siranjeevi Nagaraj, Angeles Martin-Requero, Ana Martinez

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2025.106871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Eva P Cuevas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Biológicas "Margarita Salas"-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain; Centro de Investigación Biomédica en Red en Enf…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, MicroRNAs, Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Networked Biomedical Research on Neurodegenerative Diseases, Fonds De La Recherche Scientifique - FNRS, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are a class of small, non-coding RNAs involved in different cellular functions that have emerged as key regulators of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). ALS is a fatal disease that lacks of not only effective treatments, but also presents delays in its diagnosis, since reliable clinical biomarkers are unavailable. In recent years, advancements in high-throughput sequencing strategies have led to the identification of novel ALS biomarkers, facilitating earlier diagnosis and assessment of treatment efficacy. Since immortalized lymphocytes obtained from peripheral blood are a suitable model to study pathological features of ALS, we employed these samples with the aim of characterize the dysregulated miRNAs in ALS patients. Next-generation sequencing (NGS) was utilized in order to analyze the expression profiles of miRNAs in immortalized lymphocytes from healthy controls, sporadic ALS (sALS), and familial ALS with mutations in superoxide dismutase 1 (SOD1-ALS). The screening analysis of the NGS data identified a set of dysregulated miRNAs, of which nine candidates were selected for qRT-PCR validation, identifying for the first time the possible importance of hsa-miR-6821-5p as a potential ALS biomarker. Furthermore, the up-regulated miRNAs identified are predicted to have direct or indirect interactions with genes closely related to ALS, such as SIGMAR1, HNRNPA1 and TARDBP. Additionally, by Metascape enrichment analysis, we found the VEGFA/VEGFR2 signaling pathway, previously implicated in neuroprotective effects in ALS, as a candidate pathway for further analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMicroRNAsLymphocytesHumansBiomarkersMiddle AgedFemaleMaleAgedSuperoxide Dismutase-1AdultHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

ALSBiomarkerLymphoblastsmiRNA

Substanzen

MicroRNAsBiomarkersSuperoxide Dismutase-1

Autor:innen und Institutionen

  • Centro de Investigaciones Biológicas "Margarita Salas"-CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos II…
  • Departamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción, Chile.
  • Alzheimer and other tauopathies research group, ULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, ULB Neuroscience Institute, 808 route de Lennik, B-1070 Brussels, Belgium.

Förderung

  • Center for Networked Biomedical Research on Neurodegenerative Diseases
  • Fonds De La Recherche Scientifique - FNRS
  • Ministerio de Ciencia e Innovación
  • Caixabank SA

Zitieren

APA

Cuevas, E. P., Madruga, E., Valenzuela-Martínez, I., Ramírez, D., Gil, C., Nagaraj, S., Martin-Requero, A., & Martinez, A. (2025). MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.106871

Vancouver

Cuevas EP, Madruga E, Valenzuela-Martínez I, Ramírez D, Gil C, Nagaraj S, et al. MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.106871

BibTeX
@article{Cuevas2025,
  author = {Cuevas, Eva P and Madruga, Enrique and Valenzuela-Martínez, Ignacio and Ramírez, David and Gil, Carmen and Nagaraj, Siranjeevi and Martin-Requero, Angeles and Martinez, Ana},
  title = {MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2025.106871}
}
Kostenlos starten →